TNF and metabolic dysfunction-associated steatohepatitis: Interestingly, anti-TNF biologics have shown favorable metabolic and hepatic effects both in experimental models of NASH, as well as in observational studies involving patients with immune-related diseases, which may provide the rationale for repurposing ant-TNF agents in the treatment of NASH, thus opening a new therapeutic window for the management of advanced NAFLD.